SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-18-000007
Filing Date
2018-01-12
Accepted
2018-01-12 16:05:11
Documents
8
Period of Report
2018-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K JPM 2018 TRANSCRIPT a8-kjpmtranscript2018.htm 8-K 33997
2 EXHIBIT 99.1 JPM TRANSCRIPT halotranscript20180109.htm EX-99.1 27782
3 halotranscript20180109001.jpg GRAPHIC 75895
4 halotranscript20180109002.jpg GRAPHIC 226661
5 halotranscript20180109003.jpg GRAPHIC 271036
6 halotranscript20180109004.jpg GRAPHIC 280351
7 halotranscript20180109005.jpg GRAPHIC 262726
8 halotranscript20180109006.jpg GRAPHIC 88067
  Complete submission text file 0001159036-18-000007.txt   1715088
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 18526034
SIC: 2836 Biological Products, (No Diagnostic Substances)